Current Edition

gastrointestinal

Heptares and ICL sign gastrointestinal R&D pact

Heptares Therapeutics, the UK-headquartered wholly-owned subsidiary of Japan’s Sosei Group, has formed a new drug research and development pact with Imperial College London focused on …

Continue Reading →